Skip to main content
20 views

Selank

Anxiolytic peptide for stress reduction and immune modulation

Selank molecular structure

Overview

Selank is a synthetic peptide developed in Russia that combines anti-anxiety effects with cognitive enhancement — without the sedation or addiction risk of traditional anti-anxiety medications. **What makes it unique?** Selank is based on tuftsin, a natural immune-regulating peptide in your body, with an added sequence to make it more stable. This gives it a dual action: it calms anxiety while sharpening mental function. **What the research shows:** • Reduces anxiety without causing drowsiness or impairment • Increases BDNF (brain-derived neurotrophic factor) — a protein crucial for learning and memory • May help with focus, memory consolidation, and mental clarity • Shows immune-modulating properties • Can reduce symptoms of alcohol withdrawal **How it works:** Selank influences multiple neurotransmitter systems including serotonin and dopamine, but in a balancing way rather than overwhelming them like some pharmaceuticals. **Typical use:** Usually administered as a nasal spray for direct brain delivery, though injectable forms exist. **Important to know:** Selank is approved in Russia for anxiety and cognitive disorders but is not FDA-approved in the United States. Research is promising but primarily from Russian institutions. --- **Sources:** Seredenin SB, et al. (2019) Bulletin of Experimental Biology and Medicine. DOI:10.1007/s10517-019-04588-9 | Zozulya AA, et al. (2008) Regulatory Peptides

Last reviewed: 2026-08-18

Identity & Aliases

Also known as

Selank (research name)tuftsin analogThr-Lys-Pro-Arg-Pro-Gly-ProSelank amidate (variant)

Status: Research compound - Anxiolytic peptide (approved in Russia)

CAS129954-34-3
PubChem11765106

Full composition (formula, molecular weight, sequence) in Quick Facts →

Research Areas

Anxiety disordersGABAergic modulationCognitionImmunomodulation

Available Evidence

Human

Russian clinical studies report anxiolytic efficacy of Selank in generalized anxiety disorder and neurasthenia, with tolerability comparable to the benzodiazepine phenazepam in a comparative study; the trials are small and published in Russian-language journals.

Animal

Rodent studies show anxiolytic-like effects and modulation of GABAergic and monoaminergic systems; Selank also displays immunomodulatory activity.

In Vitro

Laboratory studies indicate Selank affects GABA-A receptor function/expression and modulates neuropeptide metabolism; the precise molecular mechanism is not fully established.

Uncertain

The exact mechanism of anxiolysis is unresolved; clinical data come mainly from Russian-language studies with limited international replication, and there is no FDA-approved use.

Key Studies & Findings

2 studies

Benefits & Effects

26 documented

Cognitive enhancement

anecdotal

Mood improvement

anecdotal

Anxiety relief

anecdotal

Stress reduction

anecdotal

Cognitive support

anecdotal

Mood stabilization

anecdotal

Focus improvement

anecdotal

Non-sedating anxiolytic

anecdotal

Anxiolytic: Reduces anxiety via GABA receptor modulation

clinical

Anti-inflammatory: Decreases IL-1β, IL-6, TNF-α under stress

clinical

Anti-anxiety

Nootropic

Improves focus

Immunomodulation.

Anxiety reduction

anecdotal

Stress resilience

anecdotal

Memory enhancement

anecdotal

Immune system support

anecdotal

Anxiolytic effects comparable to benzodiazepines

preclinicalanxiolytic

39.6% reduction in morphine withdrawal syndrome

preclinicaladdiction

Memory protection via BDNF regulation

preclinicalcognitive

No dependence potential

preclinicalsafety

Anti-anxiety

Nootropic

Improves focus

Immunomodulation.

Side Effects & Safety

15 reported

Minimal side effects

mildrare

No dependence or memory impairment (unlike benzodiazepines)

nonenone

Nausea

MildUncommon

Mole darkening

MildUncommon

Anticoagulant effects

Mild

No embryonic toxicity

Mild

Flushing

MildUncommon

Spontaneous erections

MildUncommon

Rare hyperpigmentation issues

SevereRare

Nasal irritation

MildUncommon

Fatigue

MildUncommon

Mild headache

MildUncommon

Rare dizziness

SevereRare

Mild side effect

MildOccasional Reversible

Onset: Minutes-hours

Management: Avoid driving initially; dose adjustment

Dose-dependent

Moderate side effect

ModerateUnknown

Onset: Chronic use

Management: Evaluation needed; sold without adequate safety study

Limitations & Open Questions

Small samples, Russian-language publications with limited English abstracts, no large international randomized controlled trials; long-term safety data are sparse; outside Russia it is sold only as an unregulated research product.

Pharmacology

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from tuftsin; intranasal administration is typical in clinical studies. Its anxiolytic action is thought to involve GABAergic modulation; pharmacokinetics (including half-life) are not well characterized in published literature.

Reported Research Dosing

Reported values from research literature and community protocols. Educational reference only — not a dosing recommendation or medical advice.

200-400 mcg Daily

Route: Intranasal
Half-life: ~10 minutes

Research Protocols

Mild anxiety relief

Dose
250mcg daily
Frequency
Once daily
Route
SubQ injection

Moderate anxiety/cognitive enhancement

Dose
250mcg twice daily
Frequency
Morning and evening
Route
SubQ injection

Intensive anxiety/stress management

Dose
500mcg daily
Frequency
Divided doses
Route
SubQ injection

Cognitive enhancement/nootropic use

Dose
250-350mcg daily
Frequency
Morning only
Route
SubQ injection

PTSD/trauma support

Dose
250mcg twice daily
Frequency
Consistent timing
Route
SubQ injection

Immune support during stress

Dose
250mcg daily
Frequency
Once daily for 2-4 weeks
Route
SubQ injection

Research protocols are for educational purposes only. Always consult qualified medical professionals.

Frequently Asked Questions

Is Selank approved by the FDA?

No. It is not FDA-approved; it has been studied in Russia, where it has been used clinically for anxiety, but international regulatory approval is lacking.

How is Selank taken?

In clinical studies it is typically given intranasally; research products are also sold for laboratory use, with no standardized approved dosing.

Research Citations

1
Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons.

Povarov IS, Kondratenko RV, Derevyagin VI, Myasoedov NF, Skrebitsky VG (2017)

4
Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress.

Fomenko EV, Bobyntsev II, Ivanov AV, Belykh AE, Andreeva LA, Myasoedov NF (2019)

5
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.

Leonidovna YA, Aleksandrovna SM, Aleksandrovna TA, Aleksandrovna BO, Fedorovich MN, Aleksandrovna AL (2021)

+ 20 more citations

Related Resources

Quick Facts

Formula

C33H57N11O9

Molecular Weight

751.87

Sequence

Thr-Lys-Pro-Arg-Pro-Gly-Pro

Mechanism

Anxiolytic peptide with cognitive enhancement properties

Safety Information

Research compound only in most countries. Limited long-term safety data available.

View All Peptides